Lutetium (177Lu) Chloride
Radiopharmaceutical Precursor Solution
Used for the treatment of prostate cancer and neuroendocrine tumors.
Radiopharmaceutical Precursor Solution containing Lutetium (177Lu) Chloride and hydrochloric acid and water as excipients.
Radiopharmaceutical precursor. Not directly administered to the patient. This medicinal product is used only for labeling molecules suitable for labeling with Lu-177 radionuclide.
Guaranteed calibrated delivery every day of the week